Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2012
10/09/2012CA2403501C Non-invasive gene targeting to the brain
10/04/2012WO2012135669A1 Nitrogen ring containing compounds for treatment of inflammatory disorders
10/04/2012WO2012135304A1 Vagal nerve-based disorders
10/04/2012WO2012135097A1 Methods of targeted treatment of frontotemporal lobar degeneration
10/04/2012WO2012134943A1 Trpv1 antagonists
10/04/2012WO2012134900A1 Endopeptidase treatment of neuroendocrine disorders
10/04/2012WO2012134897A1 Treatment of sensory disturbance disorders
10/04/2012WO2012134445A1 An improved process for the preparation of paliperidone
10/04/2012WO2012134206A2 Process for the preparation of anhydrous aripiprazole crystal form ii
10/04/2012WO2012134194A2 Herbal compositions for treating neurological diseases and improving memory impairment
10/04/2012WO2012133942A1 Pluripotent stem cell capable of being isolated from fat tissue or umbilical cord of biological body
10/04/2012WO2012133896A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012WO2012133607A1 Pyrazole compound
10/04/2012WO2012133509A1 Novel benzimidazole derivative
10/04/2012WO2012133489A1 Pharmaceutical composition for treatment or prophylaxis of neurogenic diseases
10/04/2012WO2012133358A1 Mood-disorder amelioration agent
10/04/2012WO2012131706A1 Amorphous form of vilazodone hydrochloride and process for its preparation
10/04/2012WO2012131652A1 Herbal compositions for treatment or prevention of neurological disorders
10/04/2012WO2012131640A1 Herbal compositions for treatment or prevention of neurological disorders
10/04/2012WO2012131576A1 Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease
10/04/2012WO2012131539A1 Novel bicyclic pyridinones
10/04/2012WO2012131501A1 Substituted benzimidazole compounds as cot kinase inhibitors
10/04/2012WO2012131493A1 Compositions for the treatment of neurologic disorders
10/04/2012WO2012131468A1 Crystalline forms of fused amino pyridines as hsp90 inhibitors
10/04/2012WO2012131413A1 Crystalline forms of fused amino pyridines as hsp90 inhibitors
10/04/2012WO2012131297A1 Pyrido [3',2' :4,5] thieno [3, 2-d] pyrimidin- 4 - ylamine derivatives and their therapeutical use
10/04/2012WO2012131142A1 Use of sulphamide derivatives as neuroprotectors
10/04/2012WO2012131080A1 Aminoquinoxaline derivatives for treatment of neurodegenerative diseases
10/04/2012WO2012131031A1 New positive allosteric modulators of nicotinic acetylcholine receptor
10/04/2012WO2012130837A1 Solid agomelatine in non-crystalline form
10/04/2012WO2012130183A1 [1,3,4] oxadiazole derivative and application thereof
10/04/2012WO2012130160A1 Aminopyridine derivatives containing acridine ring and use thereof
10/04/2012WO2012130153A1 Quinolinone derivatives and use thereof as medicament against schizophrenia
10/04/2012WO2012130116A1 Compound preparation treating alzheimer's disease and preparation method thereof
10/04/2012WO2012129966A1 Paeoniflorin compound having inhibitory activity on abnormal expression of cyclooxygenase-2, preparation method therefor, and use thereof
10/04/2012WO2012129942A1 Chiral 3-hydroxypyrid-4-one derivative, and synthesis and use thereof
10/04/2012WO2012129802A1 Pyrano[3,2-d]thiazol derivatives and uses as selective glycosidase inhibitors thereof
10/04/2012WO2012129759A1 Oral dosage formulations containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
10/04/2012WO2012129629A1 Active fraction of paullinia cupana with improved activity against fatigue, method for producing an active fraction, use, pharmaceutical composition, medicament and method for the treatment of fatigue
10/04/2012WO2012095509A8 Composition for accelerating alcohol metabolism and for reducing the risk of alcohol induced diseases
10/04/2012WO2012093127A3 Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease
10/04/2012WO2012071027A3 Nutraceutical based topical anxiolytic agent and method of use
10/04/2012US20120253219 Methods for Recommending Neurophysiological Disorder Therapy
10/04/2012US20120252902 Treatment of adhd
10/04/2012US20120252901 Agomelatine and pharmaceutical compositions thereof
10/04/2012US20120252888 Compositions and Methods for Treating Neurologic Disorders
10/04/2012US20120252886 Catechins for the treatment of amyloidosis
10/04/2012US20120252885 Dronabinol treatment for migraines
10/04/2012US20120252879 Modulation of huntingtin expression
10/04/2012US20120252877 Methods and compositions for treatment of tuberous sclerosis complex
10/04/2012US20120252874 Methods for delivery of sirna to the spinal cord and therapies arising therefrom
10/04/2012US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
10/04/2012US20120252865 Carbamate derivatives in particular for the treatment of neurological disorders
10/04/2012US20120252864 Substituted isoindoline-1,3-dione derivatives
10/04/2012US20120252859 Tricyclic Indeno-Pyrrole Derivatives as Serotonin Receptor Modulators
10/04/2012US20120252858 Compounds, compositions, and methods for the treatment of beta-amyloid diseases and synucleinopathies
10/04/2012US20120252857 Genotype specific methods for treating human subjects using 4-methylpyrazole
10/04/2012US20120252853 Positive allosteric modulators of nicotinic acetylcholine receptor
10/04/2012US20120252851 Delivery system for sustained release of a calcium-channel blocking agent
10/04/2012US20120252846 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/04/2012US20120252845 Composition for sustained drug delivery comprising geopolymeric binder
10/04/2012US20120252842 Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
10/04/2012US20120252841 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators
10/04/2012US20120252838 Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
10/04/2012US20120252837 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/04/2012US20120252833 Sustained-release product comprising a combination of a non-opioid amine and a non-steriodal anti-inflammatory drug
10/04/2012US20120252832 Abuse-resistant controlled-release opioid dosage form
10/04/2012US20120252830 Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
10/04/2012US20120252828 Pyridoquinazolinone m1 receptor positive allosteric modulators
10/04/2012US20120252824 Drug Combinations and Uses in Treating a Coughing Condition
10/04/2012US20120252823 Adenosine receptor agonists, partial agonists, and antagonists
10/04/2012US20120252819 Solid dispersion formulations and methods of use thereof
10/04/2012US20120252817 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
10/04/2012US20120252815 Inhibitors of sphingosine kinase
10/04/2012US20120252813 Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/04/2012US20120252812 6-pyrimidinyl-pyrimid-4-one derivative
10/04/2012US20120252809 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
10/04/2012US20120252808 Quinoline amide m1 receptor positive allosteric modulators
10/04/2012US20120252805 Novel compounds
10/04/2012US20120252800 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
10/04/2012US20120252799 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/04/2012US20120252798 Indole compounds as an inhibitor of cellular necrosis
10/04/2012US20120252794 Analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
10/04/2012US20120252793 Intranasal benzodiazepine pharmaceutical compositions
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252788 5ht2c receptor modulators
10/04/2012US20120252784 2,3,4-benzothiadiazepine-2,2-dioxide derivatives
10/04/2012US20120252777 Thiazolopyrimidine compounds
10/04/2012US20120252758 Novel Bicyclic Pyridinones
10/04/2012US20120252750 Formulations for reducing neuronal degeneration
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252734 Inhibitors of antigen presentation by mhc class ii molecules
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252726 Novel neurotrophic factors
10/04/2012US20120252722 Metal-binding therapeutic peptides
10/04/2012US20120252719 Water soluble membrane proteins and methods for the preparation and use thereof
10/04/2012US20120251637 Abuse-proofed dosage form
10/04/2012US20120251629 Methods of treatment and screening assays for hif-1alpha regulation
10/04/2012US20120251616 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
10/04/2012US20120251610 Nicotine-containing patch preparation
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 1833